INTRA VITREOUS BEVACIZUMAB VERSUS OBSERVATION IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY.
Abstract
ABSTRACT:
OBJECTIVE: To compare the efficacy of intravitreal bevacizumab for absorption of sub-retinal fluid in central serus chorio retinopathy from observation alone.
ABSTRACT: It was a retrospective study of 34 patients with acute central serous chorioretinopathy. Patients were divided in two groups. Group A of 17 patients with anti VEGF treatment and group B of 17 patients with observation alone. Central foveal thickness and resolution of sub retinal fluid on OCT were assessed to determine the resolution of central serous retinopathy.
RESULTS: Resolution of sub retinal fluid was observed in all patients, in anti VEGF group A as well as in group B patients at 12 months.
CONCLUSION: In terms of resolution of sub retinal fluid anti VEGF as well as observation alone had similar therapeutic effects in acute central serous chorioretinopathy.
This work is licensed under a Creative Commons Attribution 4.0 International License.